Robert W. Baldridge
Keine laufenden Positionen mehr
Profil
Robert W.
Baldridge has been a Director of GTC Biotherapeutics, Inc. since 1994.
He provided consulting services to GTC Biotherapeutics from October 1994 to October 2000.
He has been an Independent Business Consultant since June 1988.
Mr. Baldridge was Chief Executive Officer and Chairman of TSI Corp.
from 1993 to 1994.
Ehemalige bekannte Positionen von Robert W. Baldridge
| Unternehmen | Position | Ende |
|---|---|---|
| REVO BIOLOGICS INC | Direktor/Vorstandsmitglied | 01.10.2009 |
| TSI Corp | Vorsitzender | 01.01.1994 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
| TSI Corp | Commercial Services |
